EVLO - Evelo Biosciences Inc. (EVLO) CEO Simba Gill on Q2 2021 Results - Earnings Call Transcript

Evelo Biosciences, Inc. (EVLO) Q2 2021 Earnings Conference Call July 29, 2021 08:30 ET Company Participants Jessica Cotrone - Investor Relations Simba Gill - Chief Executive Officer Mark Plinio - Chief Commercial Officer Jonathan Zung - Chief Development Officer Mark Bodmer - President, R&D and Chief Scientific Officer Conference Call Participants Vikram Purohit - Morgan Stanley Chris Howerton - Jefferies Matthew Luchini - BMO Capital Gobind Singh - JMP Securities Joe Thome - Cowen Presentation Operator Good morning and welcome to Evelo Biosciences Conference Call to discuss its Second Quarter 2021 Financial Results and Business Highlights. [Operator Instructions] Please be advised that this call is being recorded at the company’s request. At this time, I’d like to turn the call over to Jessica Cotrone of Evelo. Please proceed. Jessica Cotrone Thank you. This morning, we issued a press release that outlines the topics we plan to discuss today. This release

For further details see:

Evelo Biosciences, Inc. (EVLO) CEO Simba Gill on Q2 2021 Results - Earnings Call Transcript